ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients

Chen, Xinhua; Zhang, Huimin; Wang, Minghao; Liu, Hao; Hu, Yanfeng; Lin, Tian; Chen, Hao; Zhao, Mingli; Chen, Tao; Li, Guoxin; Yu, Jiang*; Zhao, Liying*南方医科大学; 1
Frontiers in Immunology2022-3-25DOI: 10.3389/fimmu.2022.783695
7被引17阅读
引用收藏
分享

摘要

Background: Antibodies against programmed death 1 (PD-1) and its ligand, programmed death-ligand 1 (PD-L1) have recently shown promising results in gastric cancer (GC). However, clinicians still lack predictive biomarkers for the efficacy of anti-PD-1 therapy; thus, we investigated the expression of PD-L1 in GC and further assessed its clinical relevance with other clinicopathological features. @@@ Methods: We retrospectively collected clinical data on 968 consecutive GC cases from Nanfang Hospital between November 2018 and August 2021. Discrepancy in the combined positive score (CPS) of PD-L1 protein expression between gastric mucosa biopsy and postoperative pathology were investigated. Correlations between CPS and clinicopathological parameters were determined using chi-squared test, multiple logistic aggression analysis, and linear regression analysis. @@@ Results: Among the 968 consecutive GC patients, 199 who did not receive preoperative chemotherapy or immunotherapy were tested for CPS both in gastric mucosa biopsy and postoperative pathology, and the results showed that the CPS of gastric mucosa biopsy was significantly lower than that of postoperative pathology [mean +/- SD: 5.5 +/- 9.4 vs. 13.3 +/- 17.4; M(IQR): 2(5) vs. 5(12), p<0.001)]. 62.3% of patients (579/930) had CPS >= 1, 49.2% of patients (458/930) had CPS >= 5, and 33.3% of patients (310/930) had CPS >= 10. Mismatch repair deficiency (dMMR) status was seen in 6.1% of patients (56 of 919). Positive Epstein-Barr virus (EBV) status was detected in 4.4% of patients (38 of 854). The patients with CPS >= 1/CPS >= 5/CPS >= 10 were significantly independently correlated with age, Lauren classification, Ki-67 index, and EBV status. According to linear regression analysis, PD-L1 expression was correlated with age (p<0.001), Ki-67 index (p<0.001), EBV (p<0.001), and Lauren classification (p=0.002). @@@ Conclusions: Our results confirmed that PD-L1 expression has Intratumoral heterogeneity in GC. Furthermore, the variables of age, Ki-67 index, and Lauren classification, which are common and accessible in most hospitals, are worth exploring as potential biomarkers for anti-PD-1 therapy in GC.

学科与关键词

关键词
gastric cancerPD-L1CPSKi-67biopsypathology
相关
加载中…
  • The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
    Chen, Li; Zhao, Ruihu; Sun, Hao; Huang, Rong; Pan, Hongming; Zuo, Yanjiao; Zhang, Lele; Xue, Yingwei; Li, Xingrui*; Song, Hongjiang*Frontiers in Pharmacology, 2022, 13: 833584.被引 4
  • PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer
    Li, Qing; Zhou, Zhi-Wei; Lu, Jia; Luo, Hao; Wang, Shu-Nan; Peng, Yu; Deng, Meng-Sheng; Song, Guan-Bin; Wang, Jian-Min; Wei, Xi; Wang, Dong*; Westover, Kenneth D.*; Xu, Cheng-Xiong*Molecular Therapy, 2022, 30(2): 621-631.被引 13
  • Programmed cell death-ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics
    Mou, Haibo; Yang, Qiu-an; Yu, Lanfang; Wang, Ting; Liu, Kui; Shen, Rong; Pan, Xuedong; Dai, Yi; Wan, Qing; Zhou, Fangling; Qian, Lili; Chen, Donglin; Yau, Thomas; Dong, Xiaowei; Wang, Xuemei*; Wang, Shuang*Journal of Gastroenterology and Hepatology, 2021, 36(9): 2601-2609.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-03-25
卷期
第 13 卷
页码
783695
DOI
10.3389/fimmu.2022.783695
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • C

    Chen, Xinhua (第一作者)

    1 · southern med univ

  • Z

    Zhang, Huimin

    1 · southern med univ

查看全部 12 位作者收起作者
  • W

    Wang, Minghao

    1 · southern med univ

  • L

    Liu, Hao

    1 · southern med univ

  • H

    Hu, Yanfeng

    1 · southern med univ

  • L

    Lin, Tian

    1 · southern med univ

  • C

    Chen, Hao

    1 · southern med univ

  • Z

    Zhao, Mingli

    1 · southern med univ

  • C

    Chen, Tao

    1 · southern med univ

  • L

    Li, Guoxin

    1 · southern med univ

  • Y

    Yu, Jiang (通讯)

    1 · southern med univ

  • Z

    Zhao, Liying (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417